ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,500Medicare Part D Prescriptions Filled, Including Refills

Rank: 346 out of 1128

$579K Total Retail Price of All Prescriptions

Rank: 363 out of 1128

292 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Tennessee
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

17% of this provider’s 292 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 292 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
FUROSEMIDE 458 429 55 1 7
AMLODIPINE BESYLATE 334 329* 47 2 3
LISINOPRIL 317 262 53 3 4
LEVOTHYROXINE SODIUM 302 263 46 4 1
OMEPRAZOLE 250 238 37 5 5
METOPROLOL TARTRATE 235 230* 35 6 10
ATORVASTATIN CALCIUM 227 182 38 7 8
SIMVASTATIN 218 213* 29 8 2
POTASSIUM CHLORIDE 205 186 22 9 15
SERTRALINE HCL 198 193* 26 10 22
DIOVAN 175 170* 12 11 52
PREDNISONE 175 170* 43 11 48
WARFARIN SODIUM 173 160 25 13 17
TRAMADOL HCL 165 143 22 14 29
PRAVASTATIN SODIUM 163 126 32 15 13
CLOPIDOGREL 138 112 18 16 18
DONEPEZIL HCL 136 136 15 17 35
HYDROCHLOROTHIAZIDE 128 115 26 18 14
PANTOPRAZOLE SODIUM 126 103 19 19 25
NAMENDA 117 117 12 20 44
METOPROLOL SUCCINATE 116 111* 19 21 26
POLYETHYLENE GLYCOL 3350 113 113 25 22 81
ATENOLOL 106 101* 20 23 19
ESCITALOPRAM OXALATE 106 106 13 23 53
LOSARTAN POTASSIUM 106 106 16 23 16
GLIPIZIDE 105 105 12 26 75
ADVAIR DISKUS 102 97* 17 27 67
LORAZEPAM 96 76 24 B 28 27
LANTUS 95 90* 13 29 64
MIRTAZAPINE 88 77 11 30 55
ISOSORBIDE MONONITRATE ER 88 83* 17 30 65
GABAPENTIN 83 70 15 32 11
SPIRONOLACTONE 82 77* 13 33 58
OXYCODONE HCL 81 61 14 S2 34 73
TRAZODONE HCL 78 64 14 35 39
ALLOPURINOL 76 71* 11 36 31
NOVOLOG 75 <11 <11 37 151
LOVASTATIN 71 66* 13 38 36
FENTANYL 70 65* 15 S2 39 112
PROPRANOLOL HCL 67 <11 <11 40 114
RANITIDINE HCL 66 <11 <11 41 37
IBUPROFEN 66 61* 14 41 117
FLUOXETINE HCL 60 <11 <11 43 59
KLOR-CON M20 59 54* 16 44 89
PAROXETINE HCL 57 <11 <11 45 61
CLONAZEPAM 56 <11 <11 B 46 51
METFORMIN HCL ER 54 <11 <11 47 49
SYNTHROID 51 <11 <11 48 57
VESICARE 50 <11 <11 49 133
FLUTICASONE PROPIONATE 50 45* 12 49 33
CARVEDILOL 50 <11 <11 49 21
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.